COVID-19 Response

Decentralized Clinical Trials: the future of clinical trials is now

Now more than ever, the industry needs to shift to decentralized trials – either fully virtual or hybrid approaches – to improve patient access and enrollment in research studies during the COVID-19 pandemic.

Watch our new video clip spotlighting a patient’s perspective on the positive impact decentralized trials can have on daily life.

Watch video

Risk-based Monitoring

By spotting issues earlier, we can prevent delays later. We combine our proprietary solution with those of industry-leading partners, to offer an unrivaled data surveillance service to keep your results and patients as safe as possible.

Learn more

Remote Monitoring

Parexel’s Remote Monitoring solution offers a comprehensive and structured approach to afford business continuity, subject safety, data integrity and study quality.

Learn more in our recent webinar

Navigating the changing regulatory environment

Our rapid response teams have worked on global public health crises including viral outbreaks (such as SARS, H1N1, MERS and Ebola). We have +1000 consultants, including 80+ former regulators / inspectors and public health professionals, along with industry consultants with in-depth GxP/cGMP compliance experience.

Learn more

Direct to Patient Drug Shipments

Our Clinical Trial Supplies and Logistics team put their hearts into making sure the right supplies get to the right people at the right time. Whether you are shipping to a site or directly to a patient our global depots can keep your trials moving.

Learn more

Vaccine Expertise

We are passionate about working with organizations developing antimicrobial compounds and vaccines pushing barriers of what medicine can do. And we’re as invested as you are in your antibacterial, antivirus, and antifungal clinical development.

Learn more